Holen Sie sich die Stockscreener-App
27.13
2.45%
-0.68
Vorhandelsmarkt:
27.67
0.54
+1.99%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALKS?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$27.81
Offen:
$27.79
24-Stunden-Volumen:
1.09M
Relative Volume:
0.57
Marktkapitalisierung:
$4.48B
Einnahmen:
$1.51B
Nettoeinkommen (Verlust:
$333.35M
KGV:
13.91
EPS:
1.95
Netto-Cashflow:
$315.22M
1W Leistung:
-4.97%
1M Leistung:
-6.45%
6M Leistung:
-19.92%
1J Leistung:
+2.65%
1-Tages-Spanne:
$26.99
$27.79
1-Wochen-Bereich:
$26.99
$28.45
52-Wochen-Spanne:
$25.16
$36.45
Alkermes Plc Stock (ALKS) Company Profile
Firmenname
Alkermes Plc
Sektor
Telefon
00-353-1-772-8000
Adresse
CONNAUGHT HOUSE, DUBLIN 4
Vergleichen Sie ALKS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALKS
Alkermes Plc
|
27.13 | 4.59B | 1.51B | 333.35M | 315.22M | 1.95 |
|
ZTS
Zoetis Inc
|
141.13 | 62.79B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.65 | 47.25B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
8.72 | 39.56B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.36 | 22.11B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
425.42 | 19.84B | 2.99B | 1.21B | 1.13B | 25.06 |
Alkermes Plc Stock (ALKS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Eingeleitet | Wells Fargo | Overweight |
| 2025-07-15 | Eingeleitet | Goldman | Buy |
| 2025-06-17 | Hochstufung | UBS | Neutral → Buy |
| 2025-05-28 | Eingeleitet | Needham | Buy |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2025-03-04 | Hochstufung | UBS | Sell → Neutral |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-11-05 | Hochstufung | Stifel | Hold → Buy |
| 2024-06-17 | Eingeleitet | TD Cowen | Buy |
| 2024-03-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-20 | Herabstufung | UBS | Neutral → Sell |
| 2023-11-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-24 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-10-17 | Eingeleitet | UBS | Neutral |
| 2022-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-10-14 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-16 | Eingeleitet | Piper Sandler | Neutral |
| 2022-04-22 | Fortgesetzt | Goldman | Buy |
| 2022-04-20 | Eingeleitet | Goldman | Buy |
| 2022-01-27 | Hochstufung | Cantor Fitzgerald | Hold → Overweight |
| 2021-12-01 | Eingeleitet | Citigroup | Neutral |
| 2021-10-07 | Hochstufung | Jefferies | Hold → Buy |
| 2021-09-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-10-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-07-30 | Herabstufung | Goldman | Neutral → Sell |
| 2020-02-14 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2020-02-14 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-14 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-02-06 | Eingeleitet | Mizuho | Neutral |
| 2020-01-31 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-05-31 | Eingeleitet | H.C. Wainwright | Neutral |
| 2019-05-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-12-19 | Herabstufung | Goldman | Neutral → Sell |
| 2018-12-14 | Eingeleitet | Wolfe Research | Underperform |
| 2018-12-13 | Herabstufung | Credit Suisse | Outperform → Underperform |
| 2018-11-05 | Eingeleitet | Piper Jaffray | Neutral |
| 2018-08-07 | Eingeleitet | Stifel | Hold |
| 2018-06-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-06-06 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2018-05-16 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-05-11 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Alkermes Plc Aktie (ALKS) Neueste Nachrichten
RBC Capital Upgrades Alkermes to Outperform From Sector Perform, Adjusts PT to $44 From $42 - MarketScreener
Nanotechnology Drug Delivery Market Booming Rapidly - openPR.com
Wedge Capital Management L L P NC Increases Stock Position in Alkermes plc $ALKS - MarketBeat
Atle Fund Management AB Has $6.50 Million Stake in Alkermes plc $ALKS - MarketBeat
Strs Ohio Invests $1.40 Million in Alkermes plc $ALKS - MarketBeat
Voya Investment Management LLC Purchases 27,136 Shares of Alkermes plc $ALKS - MarketBeat
Alkermes plc stock momentum explainedEarnings Overview Summary & Low Volatility Stock Suggestions - newser.com
Hedge Fund Moves: Can Noble Corporation plc Equity Warrant expand its profit margins - khodrobank.com
Is Alkermes plc being accumulated by smart money2025 Market Sentiment & Precise Swing Trade Alerts - خودرو بانک
Has Alkermes plc found a price floorWeekly Trade Report & Weekly Hot Stock Watchlists - newser.com
What’s next for narcolepsy - biocentury.com
Technical analysis overview for Alkermes plc stockJuly 2025 Volume & Risk Managed Investment Signals - newser.com
Published on: 2025-09-19 14:18:55 - newser.com
Candlestick signals on Alkermes plc stock today2025 Short Interest & Daily Risk Controlled Trade Plans - newser.com
Aug Catalysts: Does Alkermes plc have a sustainable dividendTrade Risk Report & Free Fast Entry Momentum Trade Alerts - خودرو بانک
Real time scanner hits for Alkermes plc explainedInflation Watch & Weekly Stock Performance Updates - newser.com
Live market analysis of Alkermes plcWeekly Risk Report & Consistent Income Trade Ideas - newser.com
Alkermes plc $ALKS Shares Acquired by Intech Investment Management LLC - MarketBeat
Can Alkermes plc hit a new high this monthTrade Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Smart Money: Is Alkermes plc in a long term uptrendWeekly Trade Analysis & Growth-Oriented Investment Plans - خودرو بانک
Heatmap analysis for Alkermes plc and competitors2025 Trading Volume Trends & Free Safe Entry Trade Signal Reports - newser.com
HC Wainwright Affirms Alkermes (ALKS) ‘Neutral’ Rating on Vibrance-1 Phase 2 Study - Yahoo Finance
Is a relief rally coming for Alkermes plc holdersPortfolio Return Report & Weekly Market Pulse Updates - newser.com
Is Alkermes plc building a consolidation baseMarket Movers & Risk Controlled Stock Alerts - newser.com
VIX Spike: What analysts say about Alkermes plc stockJuly 2025 Highlights & Long-Term Capital Growth Strategies - خودرو بانک
Leading companies in this space include Aadi Bioscience, - openPR.com
Alkermes plc (NASDAQ:ALKS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Acadian Asset Management LLC Has $29.10 Million Holdings in Alkermes plc $ALKS - MarketBeat
Fed Watch: Is Alkermes plc stock undervalued right nowJuly 2025 Big Picture & Low Risk High Reward Trade Ideas - خودرو بانک
Strategies to average down on Alkermes plcMarket Sentiment Report & Free Daily Entry Point Trade Alerts - newser.com
Alkermes Appoints Joshua Reed as New CFO - MSN
Pullback Watch: Will Alkermes plc outperform during market rallies2025 Pullback Review & Accurate Buy Signal Alerts - خودرو بانک
Rate Cut: What is the implied volatility of Alkermes plcJuly 2025 Market Mood & Weekly Chart Analysis and Trade Guides - خودرو بانک
Bearish Setup: What is the implied volatility of Alkermes plcJuly 2025 WrapUp & Fast Entry High Yield Tips - خودرو بانک
Travel Stocks: What is the implied volatility of Alkermes plcJuly 2025 Decliners & AI Powered Buy/Sell Recommendations - خودرو بانک
AQR Capital Management LLC Sells 279,276 Shares of Alkermes plc $ALKS - MarketBeat
Alkermes' CFO Iain Brown passes away - MSN
Whale Trades: Can Alkermes plc maintain sales growthJuly 2025 Update & Verified Entry Point Signals - خودرو بانک
CatalYm overhauls C-suite - biocentury.com
Tech Rally: Is Alkermes plc stock technically oversoldJuly 2025 Closing Moves & Free Technical Confirmation Trade Alerts - خودرو بانک
Market Review: What chart patterns are forming on WM Technology Inc. Equity WarrantEarnings Risk Summary & Community Shared Stock Ideas - خودرو بانک
Alkermes (NASDAQ:ALKS) Earns "Neutral" Rating from HC Wainwright - MarketBeat
Using data filters to optimize entry into Alkermes plc2025 Historical Comparison & Precise Swing Trade Entry Alerts - newser.com
Joshua Reed to Join Alkermes as Chief Financial Officer Starting September 15, 2025 - geneonline.com
Amundi Cuts Holdings in Alkermes plc $ALKS - MarketBeat
Alkermes (NASDAQ:ALKS) Reaches New 1-Year LowHere's Why - MarketBeat
Alkermes (NASDAQ:ALKS) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Alkermes Sees Unusually Large Options Volume (NASDAQ:ALKS) - MarketBeat
Baird Financial Group Inc. Purchases New Shares in Alkermes plc $ALKS - MarketBeat
Alkermes appoints Joshua Reed as new CFO effective Monday By Investing.com - Investing.com Australia
Alkermes appoints Joshua Reed as new CFO effective Monday - Investing.com India
Finanzdaten der Alkermes Plc-Aktie (ALKS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.91%
2.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):